Related Experiment Video
Updated: Jul 16, 2026

A Gravity-Fed Transcardial Perfusion Method for Histologic Analysis of the Mouse Central Nervous System
Published on: January 21, 2022
Single-cell atlas of neuroglial dynamics in SNCA-A53T Parkinson's disease mouse model
Binqing Qin1, Zichu Fu2, Xuanxuan Zou1
1Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Research Center for Translational Medicine of Xiangyang No. 1 People's Hospital, Hubei Provincial Clinical Research Center for Parkinson's Disease at Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Shiyan, China.
Background:
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of midbrain substantia nigra dopaminergic neurons, resulting in striatal dopamine depletion and motor dysfunction. While this pathological cascade is well-established, its underlying mechanisms remain elusive.
Methods:
To further investigate the pathological mechanisms of PD, we performed single-cell RNA sequencing of the midbrain and striatum from Hua-Syn (SNCA*A53T) transgenic (A53T) mice as a PD model.
Results:
Analysis of 22 865 midbrain and 32 117 striatal cells revealed cell-type-specific risk association. Glial populations (astrocytes, microglia, oligodendrocytes) showed significant enrichment for PD-risk genes. Variance-based clustering identified PD-enriched subclusters exhibiting upregulated inflammatory pathways, apoptotic pathways, proteostasis disruption, glutamatergic signaling dysregulation, and mitochondrial respiratory chain defects. Transcriptional regulation analysis identified genes associated with PD specific activity, including Rorb and Foxc1 in the midbrain and Dbx2 and Klf13 in the striatum. Cell-cell interactions showed that cell-to-cell signaling was enhanced, and the SEMA and CCL neuroinflammatory axes were specifically activated in the PD group.
Conclusions:
Our integrative analysis delineates the cellular and molecular architecture of the pathological process triggered by the expression of A53T mutant α-synuclein, and provides a framework for targeted therapeutic development.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
08:33Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Published on: February 28, 2016